iShares Health Innovation Active ETF (NYSEARCA:BMED) Short Interest Update

iShares Health Innovation Active ETF (NYSEARCA:BMED) saw a significant drop in short interest during the month of February. As of February 27th, there was short interest totaling 4,196 shares, a drop of 68.9% from the February 12th total of 13,489 shares. Based on an average daily volume of 3,392 shares, the short-interest ratio is presently 1.2 days. Currently, 1.3% of the company’s stock are short sold. Currently, 1.3% of the company’s stock are short sold. Based on an average daily volume of 3,392 shares, the short-interest ratio is presently 1.2 days.

iShares Health Innovation Active ETF Stock Down 0.5%

BMED traded down $0.15 during trading hours on Friday, hitting $28.63. 3,631 shares of the company’s stock were exchanged, compared to its average volume of 6,099. The stock has a market cap of $9.16 million, a price-to-earnings ratio of 24.91 and a beta of 0.84. iShares Health Innovation Active ETF has a 1-year low of $20.57 and a 1-year high of $32.19. The stock’s 50-day moving average is $30.81 and its two-hundred day moving average is $29.25.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in iShares Health Innovation Active ETF stock. Sunbelt Securities Inc. acquired a new stake in iShares Health Innovation Active ETF (NYSEARCA:BMED) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 11,612 shares of the company’s stock, valued at approximately $352,000. Sunbelt Securities Inc. owned approximately 3.63% of iShares Health Innovation Active ETF at the end of the most recent reporting period.

iShares Health Innovation Active ETF Company Profile

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.